These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 20946285)

  • 1. Prevalence and persistence of depression in patients with implantable cardioverter defibrillator: a 2-year longitudinal study.
    Suzuki T; Shiga T; Kuwahara K; Kobayashi S; Suzuki S; Nishimura K; Suzuki A; Ejima K; Manaka T; Shoda M; Ishigooka J; Kasanuki H; Hagiwara N
    Pacing Clin Electrophysiol; 2010 Dec; 33(12):1455-61. PubMed ID: 20946285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-implantation implantable cardioverter defibrillator concerns and Type D personality increase the risk of mortality in patients with an implantable cardioverter defibrillator.
    Pedersen SS; van den Broek KC; Erdman RA; Jordaens L; Theuns DA
    Europace; 2010 Oct; 12(10):1446-52. PubMed ID: 20719779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of symptomatic heart failure and psychological status to persistent depression in patients with implantable cardioverter-defibrillator.
    Pedersen SS; Hoogwegt MT; Jordaens L; Theuns DA
    Am J Cardiol; 2011 Jul; 108(1):69-74. PubMed ID: 21529736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of depression on mortality in implantable cardioverter defibrillator recipients--findings from the prospective LICAD study.
    Tzeis S; Kolb C; Baumert J; Reents T; Zrenner B; Deisenhofer I; Ronel J; Andrikopoulos G; Ladwig KH
    Pacing Clin Electrophysiol; 2011 Aug; 34(8):991-7. PubMed ID: 21438895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of age, gender, and race on the prevalence of depression in heart failure patients.
    Gottlieb SS; Khatta M; Friedmann E; Einbinder L; Katzen S; Baker B; Marshall J; Minshall S; Robinson S; Fisher ML; Potenza M; Sigler B; Baldwin C; Thomas SA
    J Am Coll Cardiol; 2004 May; 43(9):1542-9. PubMed ID: 15120809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlates of patient acceptance of the cardioverter defibrillator: cross-validation of the Florida Patient Acceptance Survey in Danish patients.
    Pedersen SS; Spindler H; Johansen JB; Mortensen PT; Sears SF
    Pacing Clin Electrophysiol; 2008 Sep; 31(9):1168-77. PubMed ID: 18834469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-blocker therapy is not associated with symptoms of depression and anxiety in patients receiving an implantable cardioverter-defibrillator.
    Hoogwegt MT; Kupper N; Theuns DA; Jordaens L; Pedersen SS
    Europace; 2012 Jan; 14(1):74-80. PubMed ID: 21920910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anxiety and depression in implanted cardioverter-defibrillator recipients and heart failure: a review.
    Freedenberg V; Thomas SA; Friedmann E
    Heart Fail Clin; 2011 Jan; 7(1):59-68. PubMed ID: 21109208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posttraumatic stress symptoms and predicted mortality in patients with implantable cardioverter-defibrillators: results from the prospective living with an implanted cardioverter-defibrillator study.
    Ladwig KH; Baumert J; Marten-Mittag B; Kolb C; Zrenner B; Schmitt C
    Arch Gen Psychiatry; 2008 Nov; 65(11):1324-30. PubMed ID: 18981344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience with implantable cardioverter-defibrillator therapy in grown-ups with congenital heart disease.
    Tomaske M; Bauersfeld U
    Pacing Clin Electrophysiol; 2008 Feb; 31 Suppl 1():S35-7. PubMed ID: 18226033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptomatic heart failure is the most important clinical correlate of impaired quality of life, anxiety, and depression in implantable cardioverter-defibrillator patients: a single-centre, cross-sectional study in 610 patients.
    Johansen JB; Pedersen SS; Spindler H; Andersen K; Nielsen JC; Mortensen PT
    Europace; 2008 May; 10(5):545-51. PubMed ID: 18378633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time-dependence of appropriate implantable defibrillator therapy in patients with ischemic cardiomyopathy.
    Alsheikh-Ali AA; Homer M; Maddukuri PV; Kalsmith B; Estes NA; Link MS
    J Cardiovasc Electrophysiol; 2008 Aug; 19(8):784-9. PubMed ID: 18284493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective 1-year study of changes in neuropsychological functioning after implantable cardioverter-defibrillator surgery.
    Hallas CN; Burke JL; White DG; Connelly DT
    Circ Arrhythm Electrophysiol; 2010 Apr; 3(2):170-7. PubMed ID: 20197542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them?: data from the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry.
    Schwartz PJ; Spazzolini C; Priori SG; Crotti L; Vicentini A; Landolina M; Gasparini M; Wilde AA; Knops RE; Denjoy I; Toivonen L; Mönnig G; Al-Fayyadh M; Jordaens L; Borggrefe M; Holmgren C; Brugada P; De Roy L; Hohnloser SH; Brink PA
    Circulation; 2010 Sep; 122(13):1272-82. PubMed ID: 20837891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long QT syndrome in children in the era of implantable defibrillators.
    Etheridge SP; Sanatani S; Cohen MI; Albaro CA; Saarel EV; Bradley DJ
    J Am Coll Cardiol; 2007 Oct; 50(14):1335-40. PubMed ID: 17903632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study.
    Whang W; Mittleman MA; Rich DQ; Wang PJ; Ruskin JN; Tofler GH; Muller JE; Albert CM;
    Circulation; 2004 Mar; 109(11):1386-91. PubMed ID: 14993132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychological impact of implantable cardioverter defibrillator on their recipients.
    Wheeler EC; Pretzer-Aboff I; Hardie T; Disabatino A; Saylor J; Lucey R
    Dimens Crit Care Nurs; 2009; 28(4):176-81. PubMed ID: 19546727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syncope predicts the outcome of cardiomyopathy patients: analysis of the SCD-HeFT study.
    Olshansky B; Poole JE; Johnson G; Anderson J; Hellkamp AS; Packer D; Mark DB; Lee KL; Bardy GH;
    J Am Coll Cardiol; 2008 Apr; 51(13):1277-82. PubMed ID: 18371559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depression and anxiety symptoms are associated with reduced dietary adherence in heart failure patients treated with an implantable cardioverter defibrillator.
    Luyster FS; Hughes JW; Gunstad J
    J Cardiovasc Nurs; 2009; 24(1):10-7. PubMed ID: 19114795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable cardioverter defibrillators and their role in heart failure progression.
    Cevik C; Perez-Verdia A; Nugent K
    Europace; 2009 Jun; 11(6):710-5. PubMed ID: 19357142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.